ScinoPharm, Maxigen Plan Sales Expansions Beyond Taiwan
This article was originally published in PharmAsia News
Executive Summary
ScinoPharm Taiwan and Maxigen Biotech, both Taiwan-based, separately have taken steps to expand their sales potential, ScinoPharm with more active pharmaceutical ingredients, Maxigen with its cataract drug in China.